Menu
MapConnectionsTopicsBulgariaThe Night (K-TRIO)Marie Skłodowska-CurieFor studentsFor teachersMethodologySurprise me
H2020Doctoral network2016–2020

ND4ID · New Diagnostics for Infectious Diseases: “ND4ID”

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2016-03-01 → 2020-02-29
EU contribution
€3,860,508
Participants
23
Scheme
MSCA-ITN-ETN

Lines connect the coordinator with its partners.

Results in brief

New Diagnostics for Infectious Diseases: “ND4ID”

Infectious diseases are a major burden to public health and the global economy, not in the least due to antimicrobial resistance. Rapid point of care (POC) in vitro diagnostics (IVD) are key tools in the effective clinical management of patients with infectious diseases. Yet there is still a large unmet clinical need for more rapid POC IVDs generating more clinically relevant, actionable information. Effectively addressing this need requires a change in the current approach in training researchers on IVDs, generating a new ‘breed’ of IVD researchers capable of closing the gap between the clinical and technological perspective. ND4ID takes up this challenge by offering 15 ESRs a world-class first of its kind training programme where they will be exposed to the full breadth of disciplines spanning clinical, technological and market-oriented viewpoints, from both the academic and non-academic sector. Through a set of synergistic research projects on novel POC assays, targeting the most important and urgent clinical needs at world leading academic or private sector research groups, the ESRs are offered a holistic training program, preparing them to be lead players in the future IVD field. This training through research is augmented by a unique comprehensive network-wide training programme covering clinical, technical and translational knowledge and skills of relevance to IVD research, development and exploitation. As such, ND4ID will deliver ESRs that will be in high demand serving as an example for other academic and non-academic actors active in training IVD researchers and further strengthening Europe’s position in the internally competitive arena of IVD technology.

Data: CORDIS, © European Union

Project objective

Infectious diseases are a major burden to public health and the global economy, not in the least due to antimicrobial resistance. Rapid point of care (POC) in vitro diagnostics (IVD) are key tools in the effective clinical management of patients with infectious diseases. Yet there is still a large unmet clinical need for more rapid POC IVDs generating more clinically relevant, actionable information. Effectively addressing this need requires a change in the current approach in training researchers on IVDs, generating a new ‘breed’ of IVD researchers capable of closing the gap between the clinical and technological perspective. ND4ID takes up this challenge by offering 15 ESRs a world-class first of its kind training programme where they will be exposed to the full breadth of disciplines spanning clinical, technological and market-oriented viewpoints, from both the academic and non-academic sector. Through a set of synergistic research projects on novel POC assays, targeting the most important and urgent clinical needs at world leading academic or private sector research groups, the ESRs are offered a holistic training program, preparing them to be lead players in the future IVD field. This training through research is augmented by a unique comprehensive network-wide training programme covering clinical, technical and translational knowledge and skills of relevance to IVD research, development and exploitation. As such, ND4ID will deliver ESRs that will be in high demand serving as an example for other academic and non-academic actors active in training IVD researchers and further strengthening Europe’s position in the internally competitive arena of IVD technology.

Original text from CORDIS.

Participants

  • UNIVERSITEIT ANTWERPEN · AntwerpenCoordinatorBelgium
  • AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS · MadridSpain
  • BIOCARTIS NV · MechelenBelgium
  • BIOMERIEUX SA · Marcy-l'EtoileFrance
  • DANMARKS TEKNISKE UNIVERSITET · Kongens LyngbyDenmark
  • DOC Research bv · LELYSTADNetherlands
  • E-Bug · LondonUnited Kingdom
  • ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE · LausanneSwitzerland
  • GALAPAGOS · MECHELENBelgium
  • GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED · LONDONUnited Kingdom
  • JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA · BEERSEBelgium
  • KATHOLIEKE UNIVERSITEIT LEUVEN · LeuvenBelgium
  • KUNGLIGA TEKNISKA HOEGSKOLAN · StockholmSweden
  • LEWIS TREVOR STANLEY MEDICAL DEVICE CONSULTANCY · ShropshireUnited Kingdom
  • MICROFLUIDIC CHIPSHOP GMBH · JenaGermany
  • NXP SEMICONDUCTORS NETHERLANDS BV · EindhovenNetherlands
  • STOCKHOLMS UNIVERSITET · StockholmSweden
  • Semiotics · BerlareBelgium
  • TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY · HaifaIsrael
  • THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD · OxfordUnited Kingdom
  • UNIVERSITAIR ZIEKENHUIS ANTWERPEN · EdegemBelgium
  • UNIVERSITE DE GENEVE · GeneveSwitzerland
  • UNIVERSITEIT GENT · GentBelgium

Links

Data: CORDIS, © European Union